Explore the vast range of titles available.

Sepsis-associated liver injury (SALI) increases mortality in critically ill patients but lacks targeted treatments. Although the natural compound Paeoniflorin shows anti-inflammatory and immunomodulatory potential, its specific function and mechanism in SALI remain unclear. A murine model of polymicrobial sepsis was established using cecal ligation and puncture (CLP). Male C57BL/6 mice were randomly allocated to Sham, CLP, CLP+Paeoniflorin (30, 60, 120 mg/kg), CLP+Paeoniflorin+TLR4 agonist (RS09 TFA), and Paeoniflorin-only control groups. Liver injury was assessed through serum ALT/AST measurements, histopathological evaluation, and TUNEL apoptosis assay. Hepatic inflammatory cytokine expression was quantified by qPCR. Macrophage polarization was analyzed via immunohistochemistry for F4/80, CD86 (M1), and CD206 (M2) markers. TLR4/NF-κB pathway activity was examined using Western blotting and immunohistochemistry. Transcriptomic profiling was performed through RNA sequencing and KEGG pathway analysis. Paeoniflorin administration significantly attenuated CLP-induced elevations in serum ALT and AST levels in a dose-dependent manner, ameliorated histopathological liver damage, and reduced hepatocyte apoptosis. Treatment with Paeoniflorin substantially downregulated hepatic mRNA expression of pro-inflammatory cytokines (IL-6, TNF-α, IL-1β). Immunohistochemical analysis revealed that Paeoniflorin treatment was associated with a shift in macrophage marker expression, characterized by a reduction in cells co-staining for F4/80 and the classic M1 marker CD86, and an increase in cells co-staining for F4/80 and the classic M2 marker CD206. This suggests a potential modulation of macrophage polarization balance towards an anti-inflammatory phenotype. Both transcriptomic and protein analyses confirmed that Paeoniflorin suppressed activation of the TLR4/NF-κB signaling pathway. The protective effects of Paeoniflorin were completely abolished by co-administration of the TLR4 agonist RS09 TFA. Paeoniflorin confers protection against sepsis-induced liver injury by modulating macrophage polarization from the pro-inflammatory M1 phenotype toward the anti-inflammatory M2 phenotype through inhibition of the TLR4/NF-κB signaling pathway. These findings identify Paeoniflorin as a promising candidate for further development as an immunomodulatory therapy for SALI.

Sepsis-related acute liver injury (SALI) is a severe and life-threatening complication in septic patients, for which current therapeutic options are limited. This study aimed to investigate the potential protective role of taurochenodeoxycholic acid (TCDCA) against SALI and to elucidate the underlying mechanisms. A cecal ligation and puncture (CLP) mouse model was employed to induce SALI. The effects of TCDCA treatment were assessed by measuring serum liver injury markers (AST, ALT) and pro-inflammatory cytokines (IL-6, TNF-α, IL-1β). Liver histology, hepatocyte apoptosis, and the macrophage response were evaluated. Molecular docking was used to predict the interaction between TCDCA and the receptor TGR5, which was functionally validated using the TGR5 antagonist SBI-115. Transcriptomic analysis and Western blotting were performed to identify the key signaling pathways involved. TCDCA treatment significantly reduced serum levels of AST and ALT, suppressed the production of IL-6, TNF-α, and IL-1β, and alleviated histological liver damage, including lobular disruption, inflammation, and hemorrhage. TCDCA also decreased hepatocyte apoptosis and modulated the liver macrophage response. Molecular docking confirmed a strong interaction between TCDCA and TGR5, and the protective effects of TCDCA were abolished by the TGR5 antagonist SBI-115. Transcriptomic analysis identified 430 differentially expressed genes after TCDCA treatment, with significant enrichment in pyroptosis-related pathways. Accordingly, Western blot analysis demonstrated that TCDCA inhibited the activation of the NLRP3 inflammasome and its downstream pyroptotic proteins, an effect that was also reversed by SBI-115. Our findings demonstrate that TCDCA confers a protective effect against SALI by suppressing hepatocyte pyroptosis, and this action is mediated through the TGR5 receptor. These results highlight TCDCA as a promising therapeutic candidate for SALI. However, further research, including clinical trials, is necessary to address potential species-specific differences and to fully elucidate its comprehensive mechanisms of action.

Titanium dioxide (TiO2) nanomaterials have been widely used in photocatalytic energy conversion and environmental remediation due to their advantages of low cost, chemical stability, and relatively high photo-activity. However, applications of TiO2 have been restricted in the ultraviolet range because of the wide band gap. Broadening the light absorption of TiO2 nanomaterials is an efficient way to improve the photocatalytic activity. Thus, black TiO2 with extended light response range in the visible light and even near infrared light has been extensively exploited as efficient photocatalysts in the last decade. This review represents an attempt to conclude the recent developments in black TiO2 nanomaterials synthesized by modified treatment, which presented different structure, morphological features, reduced band gap, and enhanced solar energy harvesting efficiency. Special emphasis has been given to the newly developed synthetic methods, porous black TiO2, and the approaches for further improving the photocatalytic activity of black TiO2. Various black TiO2, doped black TiO2, metal-loaded black TiO2 and black TiO2 heterojunction photocatalysts, and their photocatalytic applications and mechanisms in the field of energy and environment are summarized in this review, to provide useful insights and new ideas in the related field.

ObjectiveThere is a striking association between human cholestatic liver disease (CLD) and inflammatory bowel disease. However, the functional implications for intestinal microbiota and inflammasome-mediated innate immune response in CLD remain elusive. Here we investigated the functional role of gut–liver crosstalk for CLD in the murine Mdr2 knockout (Mdr2−/−) model resembling human primary sclerosing cholangitis (PSC).DesignMale Mdr2 −/−, Mdr2−/− crossed with hepatocyte-specific deletion of caspase-8 (Mdr2−/− /Casp8∆hepa) and wild-type (WT) control mice were housed for 8 or 52 weeks, respectively, to characterise the impact of Mdr2 deletion on liver and gut including bile acid and microbiota profiling. To block caspase activation, a pan-caspase inhibitor (IDN-7314) was administered. Finally, the functional role of Mdr2−/− -associated intestinal dysbiosis was studied by microbiota transfer experiments.Results Mdr2−/− mice displayed an unfavourable intestinal microbiota signature and pronounced NLRP3 inflammasome activation within the gut–liver axis. Intestinal dysbiosis in Mdr2−/− mice prompted intestinal barrier dysfunction and increased bacterial translocation amplifying the hepatic NLRP3-mediated innate immune response. Transfer of Mdr2−/− microbiota into healthy WT control mice induced significant liver injury in recipient mice, highlighting the causal role of intestinal dysbiosis for disease progression. Strikingly, IDN-7314 dampened inflammasome activation, ameliorated liver injury, reversed serum bile acid profile and cholestasis-associated microbiota signature.ConclusionsMDR2-associated cholestasis triggers intestinal dysbiosis. In turn, translocation of endotoxin into the portal vein and subsequent NLRP3 inflammasome activation contribute to higher liver injury. This process does not essentially depend on caspase-8 in hepatocytes, but can be blocked by IDN-7314.

Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by chronic inflammation and progressive fibrosis of the biliary tree. The majority of PSC patients suffer from concomitant inflammatory bowel disease (IBD), which has been suggested to promote disease development and progression. However, the molecular mechanisms by which intestinal inflammation may aggravate cholestatic liver disease remain incompletely understood. Here, we employ an IBD-PSC mouse model to investigate the impact of colitis on bile acid metabolism and cholestatic liver injury. Unexpectedly, intestinal inflammation and barrier impairment improve acute cholestatic liver injury and result in reduced liver fibrosis in a chronic colitis model. This phenotype is independent of colitis-induced alterations of microbial bile acid metabolism but mediated via hepatocellular NF-κB activation by lipopolysaccharide (LPS), which suppresses bile acid metabolism in-vitro and in-vivo. This study identifies a colitis-triggered protective circuit suppressing cholestatic liver disease and encourages multi-organ treatment strategies for PSC. The association between primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD) has been known for decades, but mechanisms of gut-liver crosstalk are incompletely understood. Here, the authors show a colitis-triggered protective circuit suppressing cholestatic liver disease which encourages multi-organ treatment strategies for PSC.

Background Ribosome stalling on ermBL at the tenth codon (Asp) and mRNA stabilization are believed to be mechanisms by which erythromycin (Ery) induces ermB expression. Expression of ermB is also induced by 16-membered ring macrolides (tylosin, josamycin and spiramycin), but the mechanism underlying this induction is unknown. Methods We introduced premature termination codons, alanine-scanning mutagenesis and amino acid mutations in ermBL and ermBL2. Results In this paper, we demonstrated that 16-membered ring macrolides can induce ermB expression but not ermC expression. The truncated mutants of the ermB -coding sequence indicate that the regulatory regions of ermB whose expression is induced by Ery and 16-membered ring macrolides are different. We proved that translation of the N-terminal region of ermBL is key for the induction of ermB expression by Ery, spiramycin (Spi) and tylosin (Tyl). We also demonstrated that ermBL 2 is critical for the induction of ermB expression by erythromycin but not by 16-membered ring macrolides. Conclusions The translation of ermBL and the RNA sequence of the C-terminus of ermBL are critical for the induction of ermB expression by Spi and Tyl.

The design of the hierarchical structure and geometry of nanomaterials at the molecular and macroscopic level are crucial to determine their properties and applications. In this work, we describe a facile and effective method to control over the mesostructure and morphology of ethane-bridged PMOs with the assistance of various organic salts under basic conditions. It is demonstrated that the specific interaction between the surfactant and organic salts is responsible for the shape of surfactant micelles and the formation of ethane-bridged PMOs. Specifically, the structure and the hydrophobicity of the organic salts play a major role. The addition of organic salts with more hydrophobic organic moieties, such as sodium salicylate, sodium succinate and sodium benzoate, will increase the surfactant packing parameter more effectively, leading to the mesophase change from cubic Pm3n to 2-D hexagonal P6mm structure, whereas the addition of organic salts with lower hydrophobicity and larger polar head, like sodium oxalate, will result in the mesophase transformation from cubic Pm3n to 3-D hexagonal P6 3 /mmc structure. Moreover, the addition of organic salts will not only affect the micellar formation, but also influence the charge matching at the surfactant/silicate interface as well as the condensation and aggregation kinetics of silica species. The addition of large amount of any organic salts will eventually lead to the formation of PMOs with disordered mesoporous structure. Graphical abstract

Separating He from CH4 or N2 is crucial for natural gas He extraction, a prevailing industrial approach. Herein, molecular simulation and machine learning (ML) were combined to screen 801 experimentally synthesized COFs for He/CH4 and He/N2 separation, either by means of adsorption or membrane separation. Top 10 COFs for 4 different gas separation purposes (CH4/He or N2/He separation with either adsorption or membrane) were identified respectively. The highest adsorption performance score (APSmix, defined as the product of working capacity and adsorption selectivity for mixture gas) reached 447.88 mol/kg and 49.45 mol/kg for CH4/He and N2/He, with corresponding adsorption selectivity of 115.56 and 30.33. He permeabilities of 1.5 × 106 or 1.2 × 106 Barrer were achieved for equimolar He/CH4 or He/N2 mixture gas separations, accompanied by permselectivity of 5.47 and 11.80 well surpassing 2008 Robeson's upper bound. Best performing COFs for adsorption separation are 3D COFs with pore diameter below 0.8 nm while those for membrane separation are 2D COFs with large pores. Additionally, ML models were developed to predict separation performance, with key descriptors identified. The mechanism for how COFs' structure affects their separation performance was also revealed. [Display omitted] •Top 10 COFs for 4 different gas separation purposes are identified respectively.•He/CH4 or He/N2 mixture gas separations well surpass Robeson's upper bound.•3D COFs (PLD <0.8 nm) favor adsorption, 2D COFs favor membrane separation.•ML models predict separation performance and identify key structural descriptors.•The mechanism of how COF structure influences separation performance is revealed.

Semiconductor photocatalysts are essential materials in the field of environmental remediation. Various photocatalysts have been developed to solve the contamination problem of norfloxacin in water pollution. Among them, a crucial ternary photocatalyst, BiOCl, has attracted extensive attention due to its unique layered structure. In this work, high-crystallinity BiOCl nanosheets were prepared using a one-step hydrothermal method. The obtained BiOCl nanosheets showed good photocatalytic degradation performance, and the degradation rate of highly toxic norfloxacin using BiOCl reached 84% within 180 min. The internal structure and surface chemical state of BiOCl were analyzed using scanning electron microscopy (SEM), transmission electron microscopy (TEM), Raman, Fourier transform infrared spectroscopy (FTIR), UV–visible diffuse reflectance (UV-vis), Brunauer–Emmett–Teller (BET), X-ray photoelectron spectra (XPS), and photoelectric techniques. The higher crystallinity of BiOCl closely aligned molecules with each other, which improved the separation efficiency of photogenerated charges and showed high degradation efficiency for norfloxacin antibiotics. Furthermore, the obtained BiOCl nanosheets possess decent photocatalytic stability and recyclability.

Doping engineering of metallic elements is of significant importance in photocatalysis, especially in the transition element range where metals possess empty ‘d’ orbitals that readily absorb electrons and increase carrier concentration. The doping of Mn ions produces dipole interactions that change the local structure of BiOCl, thus increasing the specific surface area of BiOCl and the number of mesoporous distributions, and providing a broader platform and richer surface active sites for catalytic reactions. The combination of Mn doping and metal Bi reduces the forbidden bandwidth of BiOCl, thereby increasing the absorption in the light region and strengthening the photocatalytic ability of BiOCl. The degradation of norfloxacin by Bi/Mn-doped BiOCl can reach 86.5% within 10 min. The synergistic effect of Mn doping and Bi metal can change the internal energy level and increase light absorption simultaneously. The photocatalytic system created by such a dual-technology combination has promising applications in environmental remediation.